Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group)-Reference-Cited by-同舟云学术

Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group)

Published:2014-12 Issue: Volume:29 Page:29-32
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Kawai Takashi¹,Takahashi Shin'ichi²,Suzuki Hidekazu³,Sasaki Hitoshi⁴,Nagahara Akihito⁴,Asaoka Daisuke⁴,Matsuhisa Takeshi⁵,Masaoaka Tatsuhiro³,Nishizawa Toshihiro⁶,Suzuki Masayuki⁶,Ito Masayoshi⁷,Kurihara Naoto⁸,Omata Fumio⁹,Mizuno Shigeaki¹⁰,Torii Akira¹¹,Kawakami Kohei¹²,Ohkusa Toshifumi¹³,Tokunaga Kengo²,Mine Tetsuya¹⁴,Sakaki Nobuhiro¹⁵

Affiliation:

1. Endoscopy Center; Tokyo Medical University; Tokyo Japan

2. Third Department of Internal Medicine; Kyorin University School of Medicine; Tokyo Japan

3. Division of Gastroenterology and Hepatology; Department of Internal Medicine; Keio University School of Medicine; Tokyo Japan

4. Department of Gastroenterology; Juntendo University School of Medicine; Tokyo Japan

5. Department of Gastrointestinal Endoscopy; Tama-Nagayama University Hospital of Nippon Medical School; Tokyo Japan

6. Division of Gastroenterology; National Hospital Organization Tokyo Medical Center; Tokyo Japan

7. Yotsuya Medical Cube; Nerima General Hospital; Tokyo Japan

8. Department of Surgery; Nerima General Hospital; Tokyo Japan

9. Department of Internal Medicine; St. Luke's International Hospital; Tokyo Japan

10. Department of Gastroenterology and Hepatology; Nihon University, School and Medicine; Tokyo Japan

11. Torii Medical Clinic; Foundation for Detection of Early Gastric Cancer; Tokyo Japan

12. Department of General Medicine & Primary Care; Tokyo Medical University; Tokyo Japan

13. Department of Gastroenterology and Hepatology; Jikei University Kashiwa Hospital; Chiba Japan

14. Department of Gastroenterology; Tokai University School of Medicine; Kanagawa Japan

15. Foundation for Detection of Early Gastric Cancer; Tokyo Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12796/fullpdf

Reference22 articles.

1. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients;Asaka;J. Gastroenterol.,2003

2. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients;Miwa;Helicobacter,2004

3. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan;Nakamura;Gut,2012

4. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review;Ando;Int. J. Hematol.,2003

5. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial;Fukase;Lancet,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study;Helicobacter;2024-07

2. Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates;Scientific Reports;2024-05-27

3. REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020;Helicobacter;2022-09-25

4. Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing;Helicobacter;2022-03-07

5. Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances;Therapeutic Advances in Gastroenterology;2022-01